P
1 mar, 2022

Hints for HEDIS® (and more)

This month’s Hints for HEDIS includes an informative refresher on the Colorectal Cancer Screening (COL) measure.

Measure Overview: The percentage of members 50-75 years of age who had an appropriate screening for colorectal cancer. The following screenings are appropriate for this measure:

Screening options
Fecal occult blood test
Sigmoidoscopia flexible
Colonoscopia
CT colonography
FIT-DNA test

Helpful reminder: Do not count digital rectal exams (DRE), or FOBT tests performed in an office setting or performed on a sample collected via DRE. Measurement period for COL measurement year 2022 are as follows:

Screening option
Measurement period
Fecal occult blood testing
During 2022
Sigmoidoscopia flexible
2018-2022
Colonoscopia
2018-2022
CT colonography
2018-2022
FIT-DNA testing
1 de enero de 2020 – 31 de diciembre de 2022

Table A: Measurement period for each colorectal cancer screening option

Helpful reminder: Physician order for a FIT-DNA test alone will not close this gap – only a collection date or test result date will close this gap.

Please refer to your 2022 PQIP Booklet for additional information on this measure.

Please do not hesitate to reach out to your BCBSRI quality representative with any questions at QualityHEDIS@bcbsri.org.